Group items tagged

Pursuant to the Foreign Assistance Act of 1961, as amended (FAA), the United States Agency for International Development (USAID) requests applications from qualified and eligible organizations to manage and implement the TRANSFORM/PRIMARY HEALTH CARE UNIT (PHCU) as described in Section I of this RFA. The overall goal of the program is to support the Government of Ethiopia (GOE) through the implementation of its new Health Sector Transformation Plan (HSTP) to End Preventable Child and Maternal Deaths (EPCMD). This RFA is issued in accordance with the Foreign Assistance Act of 1961, as amended, and the Grants and Cooperative Agreement Act of 1977. This is a full and open competition, under which any type of organization, large or small, commercial (for profit) firms, faith-based, and non-profit organizations in partnerships or consortia from geographical code 935, are eligible to compete. In accordance with the Federal Grants and Cooperative Agreement Act, USAID encourages competition in order to identify and fund the best possible applications to achieve its program objectives. While for-profit firms may participate, pursuant to 22 CFR 226.81, it is USAID policy not to award profit under assistance instruments such as cooperative agreements. However, all reasonable, allocable, and allowable expenses, both direct and indirect, which are related to the grant program and are in accordance with applicable cost standards (22 CFR 226, OMB Circular A-122 for non-profit organization, OMB Circular A-21 for universities, and the Federal Acquisition Regulation (FAR) Part 31 for-profit organizations), may be paid under the Cooperative Agreement. Using a "Design and Implement" approach, USAID anticipates issuing one mission-specific Leader Award under a Leader with Associates (LWA) arrangement. An LWA arrangement involves the issuance of a grant or cooperative agreement ("Leader Award") that covers a specified regional activity. The Leader Award includes language that all

Applications are invited in two categories: SFARI Pilot Awards and SFARI Research Awards. 1) SFARI Pilot Awards: Grants are awarded to innovative, high-impact proposals requesting support for small-scale projects or early-stage experiments designed to build on preliminary data or a prior track record and lead to competitive applications for funding by SFARI or other organizations. Investigators new to the field of autism are encouraged to apply. The maximum budget is $150,000 (including indirect costs) per year for up to two years. 2) SFARI Research Awards: Grants awarded through this category are designed for investigators with demonstrated expertise conducting compelling high-impact research on an experimental hypothesis for which, in most cases, preliminary data has already been gathered. The foundation also will consider projects focused on a central hypothesis where success depends on close collaboration between two or more labs. The initiative expects to fund proposals for a maximum of $275,000 per year (including indirect costs) for up to three years, but under exceptional circumstances will consider proposals at higher funding levels.

Applications are invited in two categories: SFARI Pilot Awards and SFARI Research Awards. 1) SFARI Pilot Awards: Grants are awarded to innovative, high-impact proposals requesting support for small-scale projects or early-stage experiments designed to build on preliminary data or a prior track record and lead to competitive applications for funding by SFARI or other organizations. Investigators new to the field of autism are encouraged to apply. The maximum budget is $150,000 (including indirect costs) per year for up to two years. 2) SFARI Research Awards: Grants awarded through this category are designed for investigators with demonstrated expertise conducting compelling high-impact research on an experimental hypothesis for which, in most cases, preliminary data has already been gathered. The foundation also will consider projects focused on a central hypothesis where success depends on close collaboration between two or more labs. The initiative expects to fund proposals for a maximum of $275,000 per year (including indirect costs) for up to three years, but under exceptional circumstances will consider proposals at higher funding levels.

The PFD Research Foundation together with the June Allyson Foundation has awarded over $1.5 million in grants to AUGS members since 1998. The Foundation serves the medical profession by supporting promising, innovative research regarding the causes, prevention, cure and treatment of pelvic floor disorders. Foundation research funds are made available to qualified AUGS members to pursue their research question. Goals of this research grant program are to support the completion of research projects which will lead to publication and presentation at future AUGS Annual Scientific Meetings and to support the development of researchers in the field who will go on to obtain additional funding for future research on pelvic floor disorders. Applicants can submit proposals for the following research awards: PFD Research Foundation Fellow Research Award: A two-year grant awarded to a fellow for clinical/patient-oriented, educational, or lab-based/basic science research. PFD Research Foundation Faculty Research Award: A two-year grant awarded to a junior faculty or affiliate member for clinical/patient-oriented, educational, or lab-based/basic science research. June Allyson Memorial Fund Research Award: A two-year grant awarded to a fellow for lab-based/basic science research. PFD Research Foundation and ICA IC/PBS Research Grant: A one-year grant awarded to a fellow, junior faculty or affiliate member of AUGS and ICA for research related to interstitial cystitis.

The Alport Syndrome Foundation (ASF) is inviting applications for the Paul Silver Enrichment Award in memory of Paul Silver, an Alport syndrome patient. Silver was a film and music editor in Hollywood who passed away in 2004 at the age of 38. In 1985, he was a Communications major studying filmmaking at Pennsylvania State University and needed a camera to document his trip to Tuscany, Italy, where was he was planning to attend a summer study program. Silver applied for, and won, the Anthony Maimone Memorial Award and was able to make a documentary film for the university about his experiences in Italy and the benefits of the program. The purpose of the award is to "pay it forward" and help other young people affected by Alport syndrome achieve one of their goals. The award can be used to complete a project or pursue an activity that will enhance the applicant's life. The program is open to individuals between the ages of 16 and 22 affected by Alport syndrome.  The award selection committee has a total of $3,000 to award, at its discretion, to one or more applications. Applicants will be evaluated on the purpose and potential impact of the award, if the award will allow the applicant to achieve their stated goal, the quality of the essay, recommendation letters, and completeness of the submission. Applications will be accepted between September 1 and November 16, 2019, with winners to be notified in early January 2020.

The Grenvik Family Award for Ethics Award honors a Society of Critical Care Medicine member who has promoted the ethical and humane delivery of critical care. The award was established in memory of Dr. Christer Grenvik, who died very early in his medical career. During his last two years of life, Christer Grenvik became deeply religious and concerned with the critically and terminally ill patient's autonomy when deciding on choice of treatment. He became particularly interested in the ethical problems in these situations and compassionate care of patients in the terminal stage. The Grenvik Family Award for Ethics Award memorializes Christer Grenvik's great concern for these issues. The recipient receives $1,000 and complimentary registration to attend the Critical Care Congress. Candidates are nominated for the award by an SCCM member or members of the award subcommittee. To be eligible, nominees must have made a significant contribution to addressing an ethical problem in critical care; be an SCCM member in good standing; and have demonstrated commitment to SCCM through involvement in SCCM committees or other SCCM activities at the local, regional, national, or international level.

Focus on Short-term Risk for Suicide (up to $1.5 million over 3 years):Letter of Intent required for this application.  AFSP offers Suicide Research Grants in six categories. Distinguished Investigator Grants (up to $100,000 over 2 years):Grants awarded to investigators at the level of associate professor or higher with an established record of research and publication on suicide.  Standard Research Grants (up to $90,000 over 2 years):Grants awarded to individual investigators at any level. Linked Standard Research Grants (up to $225,000 over 2 years):Grants awarded to investigators at any level performing research involving three or more unique sites. Young Investigator Grants (up to $85,000 over 2 years):Grants awarded to investigators at or below the level of assistant professor. These grants must allocate $10,000 ($5,000 per year) of their award for an established suicide researcher to mentor the Young Investigator. AFSP is available to assist you in identifying a suitable mentor.  Postdoctoral Research Fellowships (up to $104,000 over 2 years):Grants awarded to investigators who have received a Ph.D., M.D., or other doctoral degree within the preceding six years and have had no more than three years of fellowship support. Fellows receive a stipend of $46,000 per year and an institutional allowance of $6,000 per year.  Pilot Grants (up to $30,000 over one or two years):Awarded to investigators at any level, these grants provide seed funding for new projects that have the potential to lead to larger investigations. These grants typically entail feasibility studies rather than hypothesis-driven research. 

i. Purpose: The purpose of these activities is to support the goals of the HHS Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis, 2014-2016 (available at http://aids.gov/pdf/viral-hepatitis-action-plan.pdf) by ensuring Hepatitis B-infected pregnant women are identified so that their infants can receive timely post-exposure prophylaxis, improvements in post-vaccination serologic testing to improve efficiencies, and data collection to assess infant outcomes ii. Outcomes: Increased identification of Hepatitis B-infected pregnant women; increased rates of post-vaccination serologic testing among infants born to Hepatitis B-infected pregnant women; and assessment of factors associated with infant outcomes iii. Strategies and Activities: Collaborations: To maximize opportunities for Hepatitis B prevention through vaccination, referral for care, and treatment of persons found to have chronic Hepatitis B infection, this FOA encourages Perinatal Hepatitis B Prevention Program collaborations and service integration as a program imperative of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Such collaborations can increase efficiency, reduce redundancy, eliminate missed opportunities, and improve outcomes through the use of shared data and services. a. With CDC-funded programs: Applicants should create and build upon internal health department collaborations to improve identification of Hepatitis B-infected pregnant women; screen their household and sexual contacts for Hepatitis B and complete vaccination of susceptible persons; refer persons with chronic Hepatitis B infection for care and treatment; and report infants, household, and sexual contacts with chronic Hepatitis B infection to the National Notifiable Diseases Surveillance System. b. With organizations external to CDC: Opportunities for collaboration with non-CDC organizations will be encouraged; non-CDC organizations may include commercial laboratories and health system

Issuance Date: 3 February, 2015RFA Clarification Questions Due: 19 February, 2015; 1600 Closing Date and Time for Application Submission: 12 March, 2015; 1600 Addis Ababa Local Time Subject: Request for Applications (RFA) Number: USAID-Ethiopia- RFA-663-15-000006 RFA Title: Social and Behavior Change Communication for Health (SBCC- Health Project) EthiopiaLadies and Gentlemen: The United States Agency for International Development (USAID) is seeking applications for Assistance Agreements from all U.S. and non-U.S. qualified organizations (other than those from foreign policy restricted countries) for funding to support a program entitled Social and Behavior Change Communication for Health (SBCC- Health Project) Ethiopia. The overall goal of the program is to build the capacity of Federal Ministry of Health (FMoH) with regards to SBCC interventions while also developing effective messages and coordinating SBCC messaging across stakeholders. The authority for the RFA is found in the Foreign Assistance Act of 1961, as amended, and the Grants and Cooperative Agreement Act of 1977. While for-profit firms may participate, pursuant to 22 CFR 226.81, it is USAID policy not to award profit under assistance instruments such as cooperative agreements. However, all reasonable, allocable, and allowable expenses, both direct and indirect, which are related to the grant program and are in accordance with applicable cost standards (22 CFR 226, OMB Circular A-122 for non-profit organization, OMB Circular A-21 for universities, and the Federal Acquisition Regulation (FAR) Part 31 for-profit organizations), may be paid under the Cooperative Agreement.USAID expects to award one Cooperative Agreement based on this RFA. Subject to the availability of funds, USAID intends to allocate approximately $22.2 million funding to be allocated over a Five (5) year period. USAID reserves the right to fund any or none of the applications submitted.The Government of Ethiopia laws require prior regist

A. Noam Chomsky Global Connections Awards celebrate the power of human connections. The awards recognize distinguished service to the global mission of the STAR Scholars Network. Several individuals with a deep impact on advancing global, social mobility are recognized every year. We live in a time when innovation and creativity in support of humanity are of great importance. The Star Scholars Network recognizes the commitment of concerned people able and willing to make a difference in the lives of others. Nominations for this award are solicited from around the world. The nominee can be from any field. Beginning in 2020, the Star Scholars Network is committed to promoting transnational research, or collaborative research between scholars of two or more countries (e.g., joint publications, research partnerships, etc.). The Global Connections Awards recognize STAR Scholars for their achievements and distinctive contributions to translational research that demonstrates the very best of scholarly collaboration among scholars around the world. In December 2020, the Star Scholars Network will provide awards in three categories: North Star Medal of Lifetime Achievement, Shining Star Achievement in Research Award, Rising Star Emerging Scholar Certificate

The National Institute on Aging is pursuing this initiative to recruit talented new investigators who have begun to establish research programs and who, through this award, will be ready to assume leadership roles in their field of expertise and who will be poised to change theory, practice and health outcomes related to the health of older individuals. Unlike other mentored K awards, candidates for this award must have received competitively awarded research support as a PD/PI at the faculty level and have had prior leadership responsibilities in the clinical or research domain.

The National Institute on Aging is pursuing this initiative to recruit talented new investigators who have begun to establish research programs and who, through this award, will be ready to assume leadership roles in their field of expertise and who will be poised to change theory, practice and health outcomes related to the health of older individuals. Unlike other mentored K awards, candidates for this award must have received competitively awarded research support as a PD/PI at the faculty level and have had prior leadership responsibilities in the clinical or research domain.

The National Institute of General Medical Sciences (NIGMS) invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes with ongoing biomedical research programs funded by the NIH or other federal agencies within Institutional Development Award (IDeA) eligible states. The objectives of the COBRE initiative is to strengthen an institution's biomedical research infrastructure through the establishment of a thematic multi-disciplinary center and to enhance the ability of investigators to compete independently for complementary National Institutes of Health (NIH) individual research grants or other external peer-reviewed support. COBRE awards are supported through the IDeA Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH.

The National Institute of General Medical Sciences (NIGMS) invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at biomedical research institutions that award doctoral degrees in the health sciences or sciences related to health or at independent biomedical research institutes with ongoing biomedical research programs funded by the NIH or other federal agencies within Institutional Development Award (IDeA) eligible states. The objectives of the COBRE initiative is to strengthen an institution's biomedical research infrastructure through the establishment of a thematic multi-disciplinary center and to enhance the ability of investigators to compete independently for complementary National Institutes of Health (NIH) individual research grants or other external peer-reviewed support. COBRE awards are supported through the IDeA Program, which aims to foster health-related research by increasing the competitiveness of investigators at institutions located in states with historically low aggregate success rates for grant awards from the NIH.

A. Purpose and Priorities The National Food Safety Training, Education, Extension, Outreach, and Technical Assistance Program will award grants that increase the understanding and adoption of established food safety standards, guidance, and protocols. Grants awarded through this program will be carried out in a manner that facilitates the integration of food safety standards and guidance with a variety of agricultural production systems, including conventional, sustainable, organic, and conservation and environmental practices carried out by the eligible entities. The assistance provided by these programs, to the extent practicable, shall be coordinated with and delivered in cooperation with similar services or assistance by other federal agencies or programs serving those eligible entities. The U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) have joined in a collaborative partnership to administer and manage the National Food Safety Training, Education, Extension, Outreach, and Technical Assistance Program. This program is designed to develop a comprehensive food safety training, education and technical assistance program for those affected by the FDA Food Safety Modernization Act (FSMA). Specifically, this program will address the needs of owners and operators of small and medium-sized farms, beginning farmers, socially disadvantaged farmers, small processors, and small fresh fruit and vegetable merchant wholesalers. The joint program will award competitive grant funds that enable awardees to establish a National Coordination Center (NCC) for Food Safety Training, Education, Extension, Outreach, and Technical Assistance and Regional Centers (RC) for Food Safety Training, Education, Extension, Outreach, and Technical Assistance across the country for food safety training, education, and technical assistance. Project Teams for the RCs will reach out into local communities to work wi

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for UG3/UH3 cooperative agreements to support the development of a publicly available core set(s) of COAs and their related endpoints for specific disease indications. The UG3/UH3 Phase Innovation Award Cooperative Agreement involves 2 phases. The UG3 phase will provide funding for 1 to 2 years to conduct planning activities. The UH3 phase will provide funding for 3 to 4 years to projects that successfully complete the planning activities and reach the projected milestones set in the UG3 phase. UH3 phase awards will be awarded after administrative review of eligible UG3 phase awards that have met the scientific milestone and feasibility requirements necessary for UH3 phase implementation. The number of awards is dependent on the availability of funds. The UG3/UH3 application must be submitted as a single application, and applicants should note specific instructions for each phase in this FOA. The total award project period will not exceed 5 years.

The Vera and Joseph Dresner Foundation in West Bloomfield, Michigan, is dedicated to transforming lives in profoundly positive ways through grants focused on health, youth and animal welfare. The foundation's MDS Research Fund (MDSRF) seeks to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders and expands the foundation's investments in support of cutting-edge basic, translational, and clinical MDS research with the potential to establish future standards of care and, ultimately, a cure. The foundation will consider proposals in two categories from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders: Early Career Awards of up to $125,000 per year over two years will be awarded to eligible investigators who are less than five years from completion of their fellowship training or postdoctoral program and/or have not previously been awarded an RO1 grant or its equivalent. Established Investigator Awards of up to $250,000 per year over two years will be awarded to eligible investigators who are five or more years from completion of their fellowship training or postdoctoral program, or to applicants who have previously received an Early Career Award from the foundation or an RO1 grant or its equivalent.

The Bridge to Success for Early Career Investigators awards are designed to provide 'bridge' funding to promising early-career sleep scientists who have applied for a career development award such as a K-award grant from the NIH, a Career Development Award from the VA, or an equivalent career development grant from another federal or non-federal entity. Individuals who previously submitted an application for review, but whose applications are unlikely to be within the funding range, are eligible to apply. Through this award, the AASM Foundation aims to assist investigators at a critical juncture in their career where bridge funding can determine whether a promising sleep scientist stays in the sleep field or moves to a different career track. The funding provides support during the period of time needed for revision and resubmission of a promising application or for collection of preliminary or pilot data in response to reviewer critiques.

Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies. The Genetics or Epigenetics of Substance Use Disorders Avenir Award program supports early stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction. These may be novel methods or approaches that can potentially be applied to the analysis of the genetics or epigenetics of addiction. Investigators outside the field of addiction interested in applying their novel approaches to the genetics or epigenetics of addiction are encouraged to apply. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field of genetics or epigenetics of substance use disorders.

The NIDCD Early Career Research (ECR) Award (R21) is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. It cannot be used for thesis or dissertation research. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. The NIDCD ECR Award R21 grant mechanism supports different types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new research technology. Irrespective of the type of project, the intent of the NIDCD ECR Award R21 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application. Only one NIDCD Early Career Research Award (ECR) application may be submitted by a PD/PI per due date. Applicants will be considered ineligible for this funding opportunity if they submit an R01, R03, R15 or any other R21 application, with NIDCD as the primary IC, for the same review cycle that the NIDCD ECR Award (R21) application is submitted.

The NIH continues to operate under a Continuing Resolution as described in NOT-OD-13-002, and therefore all non-competing continuation awards are currently being funded at a level below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level).  Final levels of FY 2013 funding may be reduced by a sequestration.  Despite the potential for reduced funding, the NIH remains committed to our mission to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability.     Should a sequestration occur, NIH likely will reduce the final FY 2013 funding levels of non-competing continuation grants and expects to make fewer competing awards to  allow the agency to meet the available budget allocation. Although each NIH Institute and Center (IC) will assess allocations within their portfolio to maximize the scientific impact, non-competing continuation awards that have already been made may be restored above the current level as described in NOT-OD-13-002 but likely will not reach the full FY 2013 commitment level described in the Notice of Award. Finally, in the event of a sequestration, NIH ICs will announce their respective approaches to meeting the new budget level.

The annual award recognizes a senior researcher who has made a significant contribution to research on the causes and treatment of schizophrenia as both a researcher and a mentor. A $1,500 award will be made to the senior researcher, and $20,000 will support the research career development of a young research psychiatrist working in a mentor-trainee relationship with the award winner on further research in this field.

Researchers from across the country are invited to apply for awards for grant proposals on soy and human health for eventual submission to NIH. Incentive awards of up to $25,000 will be awarded Incentive Awards are awarded to researchers who develop the best research concepts on soy and human health. In addition to welcoming proposals dealing with soy protein, isoflavones, etc., funds have been earmarked for at least two proposals dealing with soybean oil and human health. Applications on any aspect of soy and human health will be accepted